Literature DB >> 16557352

Malignant epithelioid cranial nerve sheath tumor: case report of a radiation response.

Barbara J Fisher1, Kristopher E B Dennis.   

Abstract

Malignant epithelioid nerve sheath tumors (MESs) especially those involving intracranial cranial nerves are rare and thought to be radioresistant. We report a case of a MES involving the Vth and VIIth cranial nerves responsive to radiotherapy. A 41-year-old man with progressive left facial weakness underwent an MRI that disclosed an enhancing lesion involving both V3 cranial nerve and the distal VIIth nerve. Biopsy confirmed a malignant epithelioid schwannoma. The tumor was resected but residual tumor was present at the cut end of the infraorbital nerve, within the oral cavity and at the brainstem. Positive excision margins were irradiated to 60 Gy/30 fractions by a wedge pair technique extending from the inferior orbit to C2. Tumor was controlled for 38 months and then radiographic recurrence was resected from the infratemporal fossa outside the irradiated field.A new primary MES tumor developed at 69 months at the C1/C2 root levels at the lower edge of the previously irradiated field. It was subtotally resected but by 77 months residual tumor had grown inferiorly down to C5 so this area was re-irradiated with a complicated 7-field approach to spare spinal cord. Initially the tumor responded but ultimately progressed posteriorly where radiation dose was limited by spinal cord tolerance. New involvement of the Xth cranial nerve was noted. The patient expired from brainstem compression 7 years after initial radiotherapy. The long-term control of the original tumor despite positive margins argues for the use of radiotherapy in the treatment of these tumors.

Entities:  

Mesh:

Year:  2006        PMID: 16557352     DOI: 10.1007/s11060-005-9083-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  22 in total

1.  Epithelioid malignant schwannoma of the superficial soft tissues versus metastatic amelanotic melanoma.

Authors:  Carlos Diaz-Cascajo
Journal:  J Cutan Pathol       Date:  2002-07       Impact factor: 1.587

2.  Malignant transformation in a schwannoma.

Authors:  S J Nayler; G Leiman; T Omar; K Cooper
Journal:  Histopathology       Date:  1996-08       Impact factor: 5.087

Review 3.  Malignant epithelioid schwannoma of the mandible and the skull base.

Authors:  M B Habal
Journal:  J Craniofac Surg       Date:  1997-09       Impact factor: 1.046

Review 4.  Malignant intracerebral nerve sheath tumor: a case report and review of the literature.

Authors:  S Sharma; R I Abbott; D Zagzag
Journal:  Cancer       Date:  1998-02-01       Impact factor: 6.860

5.  Case of the month: June 1997--a 42 year old man with left facial weakness.

Authors:  D A DeRubeis; J Woulfe; D Rosso; S Lownie; L Parnes; D Lee; M J Strong; R R Hammond
Journal:  Brain Pathol       Date:  1998-01       Impact factor: 6.508

6.  Sinonasal mucosal malignant melanoma: report of an unusual case mimicking schwannoma.

Authors:  D E Kardon; L D Thompson
Journal:  Ann Diagn Pathol       Date:  2000-10       Impact factor: 2.090

7.  Malignant schwannoma--clinical characteristics, survival, and response to therapy.

Authors:  P P Sordillo; L Helson; S I Hajdu; G B Magill; C Kosloff; R B Golbey; E J Beattie
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

8.  Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.

Authors:  Jenny L Boyle; Helen M Haupt; Jere B Stern; Hinke A B Multhaupt
Journal:  Arch Pathol Lab Med       Date:  2002-07       Impact factor: 5.534

9.  Epithelioid variant of malignant peripheral nerve sheath tumor (malignant epithelioid schwannoma).

Authors:  W B Laskin; S W Weiss; G L Bratthauer
Journal:  Am J Surg Pathol       Date:  1991-12       Impact factor: 6.394

10.  Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report.

Authors:  R L Goldman; S E Jones; R S Heusinkveld
Journal:  Cancer       Date:  1977-05       Impact factor: 6.860

View more
  2 in total

Review 1.  Nuances in the treatment of malignant tumors of the clival and petroclival region.

Authors:  Ahmed Mohyeldin; Daniel M Prevedello; Ali O Jamshidi; Leo F S Ditzel Filho; Ricardo L Carrau
Journal:  Int Arch Otorhinolaryngol       Date:  2014-10

2.  Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors.

Authors:  Bénédicte L'heureux-Lebeau; Issam Saliba
Journal:  Onco Targets Ther       Date:  2013-04-26       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.